Are you considering ablation therapy for the treatment of Atrial Fibrillation?
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Mangrum J. Michael,
UVa Health System, Cardiology Division seeks adults with Atrial Fibrillation who are considering ablation treatment for research study. The purpose of the study is to test the safety and effectiveness of an investigational catheter called the CardioFocus Endoscopic Ablation System with Adaptive Contact (EAS-AC). Study involves having an ablation procedure, during which laser energy is applied directly to the spot(s) on the heart muscle that are responsible for creating erratic electrical signals that cause atrial fibrillation. The laser causes little scars to form and create blocks to the signals in an attempt to treat atrial fibrillation. Your participation in this study will require 6 study visits over a period of approximately 15 months of time. There will also be an overall assessment of health status and atrial fibrillation status at 2, 3, 4 and 5 years post-treatment. No compensation is provided for this study. For more information please contact: • Mary Jane Strickland, M.Ed. • (434) 982-6401 or MJS7W@virginia.edu • IRB-HSR #16066 Principal Investigator: Dr. J. Michael Mangrum
Cardiovascular Medicine (Heart Center)